2-Chloropyrimidine → HCID 23726021, 화합물
반응식
[F:1][C:2]1[CH:3]=[C:4]([C:9]2[C:13]([C:14]3[N:15]=[CH:16][NH:17][CH:18]=3)=[C:12]([CH3:19])[O:11][N:10]=2)[CH:5]=[CH:6][C:7]=1[F:8].Cl[C:21]1[N:26]=[CH:25][CH:24]=[CH:23][N:22]=1>>[F:1][C:2]1[CH:3]=[C:4]([C:9]2[C:13]([C:14]3[N:15]=[CH:16][N:17]([C:21]4[N:26]=[CH:25][CH:24]=[CH:23][N:22]=4)[CH:18]=3)=[C:12]([CH3:19])[O:11][N:10]=2)[CH:5]=[CH:6][C:7]=1[F:8]참가 물질
3
실험 절차
As described for Example 53, 3-(3,4-difluoro-phenyl)-4-(1H-imidazol-4-yl)-5-methyl-isoxazole (78 mg, 0.3 mmol) using 2-chloropyrimidine instead of 4-fluoroacetophenone was converted to the title compound (48 mg, 47%) which was obtained as an off-white solid. MS: m/e=406.3 [M+H]+.
출처 및 근거
- ORD 기록
- ord-700c9c3cbcc349b69156e5098f94216f
- 출처 데이터셋
- uspto-grants-2008_08
- 특허 번호
- US07414061B2
반응 노트
불러오는 중…